The influence of the microbiome on early-life severe viral lower respiratory infections and asthma-Food for thought?

Frontiers in Immunology

Volumn 8, Issue FEB, 2017, Pages

  Lynch, Jason P ^a   Sikder, Md Al Amin ^a   Curren, Bodie F ^a   Werder, Rhiannon B ^a   Simpson, Jennifer ^a   Cuív, Páraic ó ^a   Dennis, Paul G ^a   Everard, Mark L ^b   Phipps, Simon ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Asthma; Microbiome; Microbiota; Microbiota and immunity; PVM; RSV; Viral lower respiratory tract infection

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; ASTHMA; BACTERIAL FLORA; BREAST FEEDING; BRONCHIOLITIS; CELL HETEROGENEITY; CONTACT SENSITIZATION; DISEASE SEVERITY; DYSBIOSIS; HOMEOSTASIS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOPROPHYLAXIS; LACTOBACILLUS GASSERI; LUNG LAVAGE; MICROBIAL COLONIZATION; MICROBIOME; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VIRAL RESPIRATORY TRACT INFECTION;

EID: 85014418684     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00156     Document Type: Review

References (180)

1. Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med (2015) 191:34-44. doi: 10.1164/rccm.201405-0901PP
2. Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med (2012) 18:726-35. doi:10.1038/nm.2768
3. Holt PG, Sly PD. Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J Exp Med (2002) 196:1271-5. doi:10.1084/jem.20021572
4. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol (2015) 16:45-56. doi:10.1038/ni.3049
5. Holt PG, Strickland DH, Hales BJ, Sly PD. Defective respiratory tract immune surveillance in asthma: a primary causal factor in disease onset and progression. Chest (2014) 145:370-8. doi:10.1378/chest.13-1341
6. Caballero MT, Serra ME, Acosta PL, Marzec J, Gibbons L, Salim M, et al. TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest (2015) 125:571-82. doi:10.1172/JCI75183
7. Ferolla FM, Hijano DR, Acosta PL, Rodriguez A, Duenas K, Sancilio A, et al. Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children. Am J Respir Crit Care Med (2013) 187:983-90. doi:10.1164/rccm.201301-0016OC
8. Meissner HC. Viral bronchiolitis in children. N Engl J Med (2016) 374:62-72. doi:10.1056/NEJMra1413456
9. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature (2012) 486:222-7. doi:10.1038/nature11053
10. Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med (2016) 8:343ra82. doi:10.1126/scitranslmed.aad7121
11. Yassour M, Vatanen T, Siljander H, Hamalainen AM, Harkonen T, Ryhanen SJ, et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci Transl Med (2016) 8:343ra81. doi:10.1126/scitranslmed.aad0917
12. Planer JD, Peng Y, Kau AL, Blanton LV, Ndao IM, Tarr PI, et al. Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice. Nature (2016) 534:263-6. doi:10.1038/nature17940
13. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A (2011) 108(Suppl 1):4578-85. doi:10.1073/pnas.1000081107
14. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science (2012) 336:1268-73. doi:10.1126/science.1223490
15. Arpaia N, Campbell C, Fan X, Dikiy S, Van Der Veeken J, Deroos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 504:451-5. doi:10.1038/nature12726
16. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 504:446-50. doi:10.1038/nature12721
17. Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol (2016) 17:505-13. doi:10.1038/ni.3400
18. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell (2016) 167:1339.e-53.e. doi:10.1016/j.cell.2016.10.043
19. Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature (2016) 532:512-6. doi:10.1038/nature17655
20. Hasegawa K, Mansbach JM, Ajami NJ, Petrosino JF, Freishtat RJ, Teach SJ, et al. Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis. J Allergy Clin Immunol (2016). doi:10.1016/j.jaci.2016.09.037
21. Depner M, Ege MJ, Cox MJ, Dwyer S, Walker AW, Birzele LT, et al. Bacterial microbiota of the upper respiratory tract and childhood asthma. J Allergy Clin Immunol (2016). doi:10.1016/j.jaci.2016.05.050
22. Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe (2015) 17:704-15. doi:10.1016/j.chom.2015.03.008
23. Mansbach JM, Hasegawa K, Henke DM, Ajami NJ, Petrosino JF, Shaw CA, et al. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol (2016) 137:1909-1913.e4. doi:10.1016/j.jaci.2016.01.036
24. Rosas-Salazar C, Shilts MH, Tovchigrechko A, Chappell JD, Larkin EK, Nelson KE, et al. Nasopharyngeal microbiome in respiratory syncytial virus resembles profile associated with increased childhood asthma risk. Am J Respir Crit Care Med (2016) 193:1180-3. doi:10.1164/rccm.201512-2350LE
25. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2011) 127:.e1-3. doi:10.1016/j.jaci.2010.10.048
26. Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 188:1193-201. doi:10.1164/rccm.201304-0775OC
27. Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, et al. Features of the bronchial bacterial microbiome associated with atopy, asthma and responsiveness to inhaled corticosteroid treatment. J Allergy Clin Immunol (2016). doi:10.1016/j.jaci.2016.08.055
28. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al. Disordered microbial communities in asthmatic airways. PLoS One (2010) 5:e8578. doi:10.1371/journal.pone.0008578
29. Khetsuriani N, Kazerouni NN, Erdman DD, Lu X, Redd SC, Anderson LJ, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol (2007) 119:314-21. doi:10.1016/j.jaci.2006.08.041
30. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med (2008) 178:667-72. doi:10.1164/rccm.200802-309OC
31. Kusel MM, De Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol (2007) 119:1105-10. doi:10.1016/j.jaci.2006.12.669
32. Kusel MM, Kebadze T, Johnston SL, Holt PG, Sly PD. Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur Respir J (2012) 39:876-82. doi:10.1183/09031936.00193310
33. Kusel MM, De Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J (2006) 25:680-6. doi:10.1097/01.inf.0000226912.88900.a3
34. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 310:1225-9. doi:10.1136/bmj.310.6989.1225
35. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med (2005) 171:137-41. doi:10.1164/rccm.200406-730OC
36. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. J Pediatr (1995) 95:500-5.
37. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med (2000) 161:1501-7. doi:10.1164/ajrccm.161.5.9906076
38. Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax (2010) 65:1045-52. doi:10.1136/thx.2009.121582
39. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet (1999) 354:541-5. doi:10.1016/S0140-6736(98)10321-5
40. Mok JY, Simpson H. Symptoms, atopy, and bronchial reactivity after lower respiratory infection in infancy. Arch Dis Child (1984) 59:299-305. doi:10.1136/adc.59.4.299
41. James KM, Gebretsadik T, Escobar GJ, Wu P, Carroll KN, Li SX, et al. Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season. J Allergy Clin Immunol (2013) 132:227-9. doi:10.1016/j.jaci.2013.01.009
42. Wu P, Dupont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T, et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med (2008) 178:1123-9. doi:10.1164/rccm.200804-579OC
43. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 103:779-88. doi:10.1172/JCI5909
44. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 154:654-60. doi:10.1164/ajrccm.154.3.8810601
45. Rawlinson WD, Waliuzzaman Z, Carter IW, Belessis YC, Gilbert KM, Morton JR. Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. J Infect Dis (2003) 187:1314-8. doi:10.1086/368411
46. Lodge CJ, Lowe AJ, Gurrin LC, Hill DJ, Hosking CS, Khalafzai RU, et al. House dust mite sensitization in toddlers predicts current wheeze at age 12 years. J Allergy Clin Immunol (2011) 128:782.e-8.e. doi:10.1016/j.jaci.2011.06.038
47. Hasegawa S, Hirano R, Hashimoto K, Haneda Y, Shirabe K, Ichiyama T. Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals 'occult' asthma of childhood. Pediatr Allergy Immunol (2011) 22:e119-23. doi:10.1111/j.1399-3038.2010.01090.x
48. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med (2004) 350:443-50. doi:10.1056/NEJMoa025472
49. Williams JV, Crowe JE, Enriquez R, Minton P, Peebles RS, Hamilton RG, et al. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis (2005) 192:1149-53. doi:10.1086/444392
50. Jartti T, Van Den Hoogen B, Garofalo RP, Osterhaus AD, Ruuskanen O. Metapneumovirus and acute wheezing in children. Lancet (2002) 360:1393-4. doi:10.1016/S0140-6736(02)11391-2
51. Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy-the first sign of childhood asthma? J Allergy Clin Immunol (2003) 111:66-71. doi:10.1067/mai.2003.33
52. Escobar GJ, Ragins A, Li SX, Prager L, Masaquel AS, Kipnis P. Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life. Arch Pediatr Adolesc Med (2010) 164:915-22. doi:10.1001/archpediatrics.2010.177
53. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol (2005) 116:571-7. doi:10.1016/j.jaci.2005.06.024
54. Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JLL, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med (2013) 368:1791-9. doi:10.1056/NEJMoa1211917
55. Simoes EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol (2010) 126:256-62. doi:10.1016/j.jaci.2010.05.026
56. Chen CH, Lin YT, Yang YH, Wang LC, Lee JH, Kao CL, et al. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatr Allergy Immunol (2008) 19:166-72. doi:10.1111/j.1399-3038.2007.00610.x
57. Kaiko GE, Loh Z, Spann K, Lynch JP, Lalwani A, Zheng Z, et al. Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. J Allergy Clin Immunol (2013) 131:1331.e-9.e. doi:10.1016/j.jaci.2013.02.041
58. Davidson S, Kaiko G, Loh Z, Lalwani A, Zhang V, Spann K, et al. Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway. J Immunol (2011) 186:5938-48. doi:10.4049/jimmunol.1002635
59. Lynch JP, Werder RB, Simpson J, Loh Z, Zhang V, Haque A, et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol (2016) 138:1326-37. doi:10.1016/j.jaci.2016.02.039
60. Spann KM, Loh Z, Lynch JP, Ullah A, Zhang V, Baturcam E, et al. IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice. Am J Pathol (2014) 184:1795-806. doi:10.1016/j.ajpath.2014.02.026
61. Lynch JP, Mazzone SB, Rogers MJ, Arikkatt JJ, Loh Z, Pritchard AL, et al. The plasmacytoid dendritic cell: at the cross-roads in asthma. Eur Respir J (2014) 43:264-75. doi:10.1183/09031936.00203412
62. Willart MA, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht BN, et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J Exp Med (2012) 209:1505-17. doi:10.1084/jem.20112691
63. Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol (2014) 134(2):440-50. doi:10.1016/j.jaci.2013.12.1035
64. Halim TYF, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol (2016) 17:57-64. doi:10.1038/ni.3294
65. De Kleer IM, Kool M, De Bruijn MJ, Willart M, van Moorleghem J, Schuijs MJ, et al. Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung. Immunity (2016) 45:1285-98. doi:10.1016/j.immuni.2016.10.031
66. Pritchard AL, Carroll ML, Burel JG, White OJ, Phipps S, Upham JW. Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mechanism with relevance to asthma. J Immunol (2012) 188:5898-905. doi:10.4049/jimmunol.1103507
67. Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol (2004) 25:477-82. doi:10.1016/j.it.2004.07.006
68. Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog (2011) 7:e1002003. doi:10.1371/journal.ppat.1002003
69. Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature (2012) 484:465-72. doi:10.1038/nature11047
70. Oliphant CJ, Hwang YY, Walker JA, Salimi M, Wong SH, Brewer JM, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4 T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity (2014) 41(2):283-95. doi:10.1016/j.immuni.2014.06.016
71. Guo L, Huang Y, Chen X, Hu-Li J, Urban JF Jr, Paul WE. Innate immunological function of TH2 cells in vivo. Nat Immunol (2015) 16:1051-9. doi:10.1038/ni.3244
72. Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol (2016) 78:481-504. doi:10.1146/annurev-physiol-021115-105238
73. Gleeson K, Eggli DF, Maxwell SL. Quantitative aspiration during sleep in normal subjects. Chest (1997) 111:1266-72. doi:10.1378/chest.111.5.1266
74. Wilson MT, Hamilos DL. The nasal and sinus microbiome in health and disease. Curr Allergy Asthma Rep (2014) 14:485. doi:10.1007/s11882-014-0485-x
75. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med (1978) 64:564-8. doi:10.1016/0002-9343(78)90574-0
76. Zhang Q, Cox M, Liang Z, Brinkmann F, Cardenas PA, DuffR, et al. Airway microbiota in severe asthma and relationship to asthma severity and phenotypes. PLoS One (2016) 11:e0152724. doi:10.1371/journal.pone.0152724
77. Green BJ, Wiriyachaiporn S, Grainge C, Rogers GB, Kehagia V, Lau L, et al. Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. PLoS One (2014) 9:e100645. doi:10.1371/journal.pone.0100645
78. Simpson JL, Daly J, Baines KJ, Yang IA, Upham JW, Reynolds PN, et al. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. Eur Respir J (2016) 47:792-800. doi:10.1183/13993003.00405-2015
79. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ (1993) 307:982-6. doi:10.1136/bmj.307.6910.982
80. Hofstra JJ, Matamoros S, Van De Pol MA, De Wever B, Tanck MW, Wendt-Knol H, et al. Changes in microbiota during experimental human Rhinovirus infection. BMC Infect Dis (2015) 15:336. doi:10.1186/s12879-015-1081-y
81. Kloepfer KM, Lee WM, Pappas TE, Kang TJ, Vrtis RF, Evans MD, et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol (2014) 133:.e1-3. doi:10.1016/j.jaci.2014.02.030
82. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bønnelykke K, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med (2007) 357:1487-95. doi:10.1056/NEJMoa052632
83. Bisgaard H, Hermansen MN, Bønnelykke K, Stokholm J, Baty F, Skytt NL, et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ (2010) 341:c4978. doi:10.1136/bmj.c4978
84. Von Mutius E. Of attraction and rejection-asthma and the microbial world. N Engl J Med (2007) 357:1545-7. doi:10.1056/NEJMe078119
85. Penders J, Kummeling I, Thijs C. Infant antibiotic use and wheeze and asthma risk: a systematic review and meta-analysis. Eur Respir J (2011) 38:295-302. doi:10.1183/09031936.00105010
86. Rollins DR, Beuther DA, Martin RJ. Update on infection and antibiotics in asthma. Curr Allergy Asthma Rep (2010) 10:67-73. doi:10.1007/s11882-009-0086-2
87. Marra F, Lynd L, Coombes M, Richardson K, Legal M, Fitzgerald JM, et al. Does antibiotic exposure during infancy lead to development of asthma? A systematic review and metaanalysis. Chest (2006) 129:610-8. doi:10.1378/chest.129.3.610
88. Lange NE, Celedón JC, Forno E, Ly NP, Onderdonk A, Bry L, et al. Maternal intestinal flora and wheeze in early childhood. Clin Exp Allergy (2012) 42:901-8. doi:10.1111/j.1365-2222.2011.03950.x
89. Yang B, Liu R, Yang T, Jiang X, Zhang L, Wang L, et al. Neonatal Streptococcus pneumoniae infection may aggravate adulthood allergic airways disease in association with IL-17A. PLoS One (2015) 10:e0123010. doi:10.1371/journal.pone.0123010
90. Raiden S, PandolfiJ, Payasliàn F, Anderson M, Rivarola N, Ferrero F, et al. Depletion of circulating regulatory T cells during severe respiratory syncytial virus infection in young children. Am J Respir Crit Care Med (2014) 189:865-8. doi:10.1164/rccm.201311-1977LE
91. Durant LR, Makris S, Voorburg CM, Loebbermann J, Johansson C, Openshaw PJ. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J Virol (2013) 87:10946-54. doi:10.1128/JVI.01295-13
92. Brockson ME, Novotny LA, Jurcisek JA, Mcgillivary G, Bowers MR, Bakaletz LO. Respiratory syncytial virus promotes Moraxella catarrhalis-induced ascending experimental otitis media. PLoS One (2012) 7:e40088. doi:10.1371/journal.pone.0040088
93. Green CA, Yeates D, Goldacre A, Sande C, Parslow RC, Mcshane P, et al. Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma. Arch Dis Child (2015) 101(2):140-6. doi:10.1136/archdischild-2015-308723
94. Adcock IM, Caramori G, Chung KF. New targets for drug development in asthma. Lancet (2008) 372:1073-87. doi:10.1016/S0140-6736(08)61449-X
95. Eder W, Ege MJ, Erika Von M. Current concepts: the asthma epidemic. N Engl J Med (2006) 355:2226-35. doi:10.1056/NEJMra054308
96. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2007) 62:758-66. doi:10.1136/thx.2006.070169
97. Strachan DP. Hay fever, hygiene, and household size. BMJ (1989) 299:1259-60. doi:10.1136/bmj.299.6710.1259
98. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax (2000) 55(Suppl 1):S2-10. doi:10.1136/thorax.55.suppl_1.S2
99. Riedler J, Braun-Fahrlander C, Eder W, Schreuer M, Waser M, Maisch S, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet (2001) 358:1129-33. doi:10.1016/S0140-6736(01)06252-3
100. Braun-Fahrlander C, Riedler J, Herz U, Eder W, Waser M, Grize L, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med (2002) 347:869-77. doi:10.1056/NEJMoa020057
101. Gereda JE, Leung DY, Liu AH. Levels of environmental endotoxin and prevalence of atopic disease. JAMA (2000) 284:1652-3. doi:10.1001/jama.284.13.1647
102. Genuneit J, Strachan DP, Buchele G, Weber J, Loss G, Sozanska B, et al. The combined effects of family size and farm exposure on childhood hay fever and atopy. Pediatr Allergy Immunol (2013) 24:293-8. doi:10.1111/pai.12053
103. Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, et al. Innate immunity and asthma risk in Amish and Hutterite farm children. N Engl J Med (2016) 375:411-21. doi:10.1056/NEJMoa1508749
104. Schuijs MJ, Willart MA, Vergote K, Gras D, Deswarte K, Ege MJ, et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science (2015) 349:1106-10. doi:10.1126/science.aac6623
105. Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA (2002) 288:963-72. doi:10.1001/jama.288.8.963
106. Hesselmar B, Aberg N, Aberg B, Eriksson B, Bjorksten B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy (1999) 29:611-7. doi:10.1046/j.1365-2222.1999.00534.x
107. Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD, et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet (2000) 355:1680-3. doi:10.1016/S0140-6736(00)02239-X
108. Fujimura KE, Johnson CC, Ownby DR, Cox MJ, Brodie EL, Havstad SL, et al. Man's best friend? The effect of pet ownership on house dust microbial communities. J Allergy Clin Immunol (2010) 126:410-2. doi:10.1016/j.jaci.2010.05.042
109. Gravesen S. Fungi as a cause of allergic disease. Allergy (1979) 34:135-54. doi:10.1111/j.1398-9995.1979.tb01562.x
110. Pantoja-Feliciano IG, Clemente JC, Costello EK, Perez ME, Blaser MJ, Knight R, et al. Biphasic assembly of the murine intestinal microbiota during early development. ISME J (2013) 7:1112-5. doi:10.1038/ismej.2013.15
111. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 107:11971-5. doi:10.1073/pnas.1002601107
112. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology (2012) 22:1147-62. doi:10.1093/glycob/cws074
113. Mueller N, Pizoni A, Goldani H, Werlang I, Matte U, Goldani M, et al. Delivery mode and neonate gut microbiota. FASEB J (2015) 29. doi:10.1096/fj.1530-6860
114. Guaraldi F, Salvatori G. Effect of breast and formula feeding on gut microbiota shaping in newborns. Front Cell Infect Microbiol (2012) 2:94. doi:10.3389/fcimb.2012.00094
115. Jackson KM, Nazar AM. Breastfeeding, the immune response, and long-term health. J Am Osteopath Assoc (2006) 106:203-7.
116. Blaser MJ, Dominguez-Bello MG. The human microbiome before birth. Cell Host Microbe (2016) 20:558-60. doi:10.1016/j.chom.2016.10.014
117. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature (2003) 422:522-6. doi:10.1038/nature01520
118. Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A (2008) 105:20858-63. doi:10.1073/pnas.0808723105
119. Bauer H, Horowitz RE, Levenson SM, Popper H. The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. Am J Pathol (1963) 42:471-83.
120. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science (2012) 336:489-93. doi:10.1126/science.1219328
121. Julia V, Macia L, Dombrowicz D. The impact of diet on asthma and allergic diseases. Nat Rev Immunol (2015) 15:308-22. doi:10.1038/nri3830
122. Tannock GW. Analysis of the intestinal microflora using molecular methods. Eur J Clin Nutr (2002) 56(Suppl 4):S44-9. doi:10.1038/sj.ejcn.1601661
123. Hoverstad T, Carlstedt-Duke B, Lingaas E, Midtvedt T, Norin KE, Saxerholt H, et al. Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol (1986) 21:621-6. doi:10.3109/00365528608996411
124. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem (2011) 22:849-55. doi:10.1016/j.jnutbio.2010.07.009
125. Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, et al. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res (2008) 28:321-8. doi:10.1016/j.nutres.2008.02.012
126. Kendrick SF, O'BOYLE G, Mann J, Zeybel M, Palmer J, Jones DE, et al. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology (2010) 51:1988-97. doi:10.1002/hep.23572
127. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A (2014) 111:2247-52. doi:10.1073/pnas.1322269111
128. Singh N, Thangaraju M, Prasad PD, Martin PM, Lambert NA, Boettger T, et al. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J Biol Chem (2010) 285:27601-8. doi:10.1074/jbc. M110.102947
129. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med (2014) 20(2):159-66. doi:10.1038/nm.3444
130. Tao R, De Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med (2007) 13:1299-307. doi:10.1038/nm1652
131. Thorburn AN, Mckenzie CI, Shen S, Stanley D, Macia L, Mason LJ, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun (2015) 6:7320. doi:10.1038/ncomms8320
132. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (2013) 341:569-73. doi:10.1126/science.1241165
133. Mirkovic B, Murray MA, Lavelle GM, Molloy K, Azim AA, Gunaratnam C, et al. The role of short-chain fatty acids, produced by anaerobic bacteria, in the cystic fibrosis airway. Am J Respir Crit Care Med (2015) 192:1314-24. doi:10.1164/rccm.201505-0943OC
134. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med (2015) 7:307ra152. doi:10.1126/scitranslmed.aab2271
135. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 44:842-50. doi:10.1111/cea.12253
136. Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A (2013) 110:4410-5. doi:10.1073/pnas.1215927110
137. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem (2003) 278:11312-9. doi:10.1074/jbc. M211609200
138. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem (2003) 278:25481-9. doi:10.1074/jbc. M301403200
139. Nilsson NE, Kotarsky K, Owman C, Olde B. Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun (2003) 303:1047-52. doi:10.1016/S0006-291X(03)00488-1
140. Schmidt J, Smith NJ, Christiansen E, Tikhonova IG, Grundmann M, Hudson BD, et al. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J Biol Chem (2011) 286:10628-40. doi:10.1074/jbc. M110.210872
141. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, Kedzierski RM, et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc Natl Acad Sci U S A (2004) 101:1045-50. doi:10.1073/pnas.2637002100
142. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, et al. (d)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem (2005) 280:26649-52. doi:10.1074/jbc. C500213200
143. Yoshioka H, Iseki K, Fujita K. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics (1983) 72:317-21.
144. Verhasselt V, Milcent V, Cazareth J, Kanda A, Fleury S, Dombrowicz D, et al. Breast milk-mediated transfer of an antigen induces tolerance and protection from allergic asthma. Nat Med (2008) 14:170-5. doi:10.1038/nm1718
145. Scholtens S, Wijga AH, Brunekreef B, Kerkhof M, Hoekstra MO, Gerritsen J, et al. Breast feeding, parental allergy and asthma in children followed for 8 years. The PIAMA Birth Cohort Study. Thorax (2009) 64:604-9. doi:10.1136/thx.2007.094938
146. Oddy WH, De Klerk NH, Sly PD, Holt PG. The effects of respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J (2002) 19:899-905. doi:10.1183/09031936.02.00103602
147. Oddy WH, Holt PG, Sly PD, Read AW, Landau LI, Stanley FJ, et al. Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study. BMJ (1999) 319:815-9. doi:10.1136/bmj.319.7213.815
148. Bachrach VRG, Schwarz E, Bachrach LR. Breastfeeding and the risk of hospitalization for respiratory disease in infancy-a meta-analysis. Arch Pediatr Adolesc Med (2003) 157:237-43. doi:10.1001/archpedi.157.3.237
149. Cushing AH, Samet JM, Lambert WE, Skipper BJ, Hunt WC, Young SA, et al. Breastfeeding reduces risk of respiratory illness in infants. Am J Epidemiol (1998) 147:863-70. doi:10.1093/oxfordjournals.aje.a009540
150. Wright AL, Holberg CJ, Martinez FD, Morgan WJ, Taussig LM. Breast feeding and lower respiratory tract illness in the first year of life. Group Health Medical Associates. BMJ (1989) 299:946-9. doi:10.1136/bmj.299.6705.946
151. Nishimura T, Suzue J, Kaji H. Breastfeeding reduces the severity of respiratory syncytial virus infection among young infants: a multi-center prospective study. Pediatr Int (2009) 51:812-6. doi:10.1111/j.1442-200X.2009.02877.x
152. Downham MA, Scott R, Sims DG, Webb JK, Gardner PS. Breast-feeding protects against respiratory syncytial virus infections. Br Med J (1976) 2:274-6. doi:10.1136/bmj.2.6030.274
153. Simoes EAF. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr (2003) 143:118-26. doi:10.1067/S0022-3476(03)00511-0
154. Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (2010) 328:1705-9. doi:10.1126/science.1188454
155. Sonnenberg GF, Artis D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med (2015) 21:698-708. doi:10.1038/nm.3892
156. Kiss EA, Vonarbourg C, Kopfmann S, Hobeika E, Finke D, Esser C, et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science (2011) 334:1561-5. doi:10.1126/science.1214914
157. Hunt JR, Martinelli R, Adams VC, Rook GA, Brunet LR. Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model. Clin Exp Allergy (2005) 35:685-90. doi:10.1111/j.1365-2222.2005.02239.x
158. Forsythe P, Inman MD, Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med (2007) 175:561-9. doi:10.1164/rccm.200606-821OC
159. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2011) 331:337-41. doi:10.1126/science.1198469
160. Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol (2015) 135:299-310. doi:10.1016/j.jaci.2014.12.1871
161. Lynch JP, Ferreira MA, Phipps S. Th2/Th17 reciprocal regulation: twists and turns in the complexity of asthma phenotypes. Ann Transl Med (2016) 4(1):S59. doi:10.21037/atm.2016.10.69
162. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child (2006) 91:814-9. doi:10.1136/adc.2006.098251
163. Westerbeek EA, Van Den Berg A, Lafeber HN, Fetter WP, Van Elburg RM. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo-and acidic oligosaccharides on intestinal permeability in preterm infants. Br J Nutr (2011) 105:268-74. doi:10.1017/S0007114510003405
164. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol (2008) 101:570-9. doi:10.1016/S1081-1206(10)60219-0
165. Chen YS, Jan RL, Lin YL, Chen HH, Wang JY. Randomized placebo-controlled trial of Lactobacillus on asthmatic children with allergic rhinitis. Pediatr Pulmonol (2010) 45:1111-20. doi:10.1002/ppul.21296
166. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med (2009) 179:186-93. doi:10.1164/rccm.200806-951OC
167. Jang S-O, Kim H-J, Kim Y-J, Kang M-J, Kwon J-W, Seo J-H, et al. Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4(+)CD25(+)Foxp3(+) T cells. Allergy Asthma Immunol Res (2012) 4:150-6. doi:10.4168/aair.2012.4.3.150
168. Strickland DH, Judd S, Thomas JA, Larcombe AN, Sly PD, Holt PG. Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol (2011) 4:43-52. doi:10.1038/mi.2010.43
169. Van De Pol MA, Lutter R, Smids BS, Weersink EJ, Van Der Zee JS. Synbiotics reduce allergen-induced T-helper 2 response and improve peak expiratory flow in allergic asthmatics. Allergy (2011) 66:39-47. doi:10.1111/j.1398-9995.2010.02454.x
170. Chiba E, Tomosada Y, Vizoso-Pinto MG, Salva S, Takahashi T, Tsukida K, et al. Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. Int Immunopharmacol (2013) 17:373-82. doi:10.1016/j.intimp.2013.06.024
171. Arslanoglu S, Moro GE, Boehm G. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. J Nutr (2007) 137:2420-4.
172. Luoto R, Ruuskanen O, Waris M, Kalliomäki M, Salminen S, Isolauri E. Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J Allergy ClinImmunol (2014) 133:405-13. doi:10.1016/j.jaci.2013.08.020
173. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy-a randomised, double-blind, placebo-controlled study. Br J Nutr (2009) 101:1722-6. doi:10.1017/S0007114508116282
174. Taipale T, Pienihakkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P, et al. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Br J Nutr (2011) 105:409-16. doi:10.1017/S0007114510003685
175. Maldonado J, Canabate F, Sempere L, Vela F, Sanchez AR, Narbona E, et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr (2012) 54:55-61. doi:10.1097/MPG.0b013e3182333f18
176. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature (2009) 461:1282-6. doi:10.1038/nature08530
177. Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem (2003) 278:9869-74. doi:10.1074/jbc. M210695200
178. Ulven T. Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets. Front Endocrinol (2012) 3:111. doi:10.3389/fendo.2012.00111
179. Palomares O, Ruckert B, Jartti T, Kucuksezer UC, Puhakka T, Gomez E, et al. Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral tolerance. J Allergy Clin Immunol (2012) 129:510-20. doi:10.1016/j.jaci.2011.09.031
180. Kaiko G, Loh Z, Spann K, Lynch J, Lalwani A, Davidson S, et al. TLR7 gene deficiency and early-life pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice. J Allergy Clin Immunol (2013) 42:1331-9. doi:10.1016/j.jaci.2013.02.041